Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Mucociliary Clearance Following a Next-Generation Propellant Versus Hydrofluoroalkane-134a via Pressurized Metered-Dose Inhaler: A Randomized, Double-Blind, Two-Way Crossover Study in Healthy Adults.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: July 16, 2026
No Place Like Home: Home Spirometry for Cystic Fibrosis Clinical Trials.
Journal: Annals of the American Thoracic Society
Published: June 05, 2026
Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDO.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 17, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials.
Journal: The Lancet. Respiratory medicine
Published: March 20, 2025
New era, new GOALs: cardiovascular screening and lipid management in cystic fibrosis.
Journal: Therapeutic advances in respiratory disease
Published: February 01, 2025
Prevalence and predictors of substance use in adults with cystic fibrosis: A single-center retrospective review.
Journal: General hospital psychiatry
Published: September 12, 2024
Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.
Journal: American journal of respiratory and critical care medicine
Published: September 05, 2024
Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 30, 2024
Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: January 03, 2024
Analysis of Depression and Anxiety Scores Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Adults With Cystic Fibrosis.
Journal: The clinical respiratory journal
Published: November 03, 2023
Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: June 08, 2023
More is better? Hypertonic saline dose and response for cystic fibrosis: efficacy, tolerability and implications for clinical practice.
Journal: The European respiratory journal
Published: May 23, 2023
Last Updated: 09/26/2026